Cost-Effectiveness of Buprenorphine–Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse-Reference-Cited by-同舟云学术

Cost-Effectiveness of Buprenorphine–Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse

Published:2018-12-18 Issue:2 Volume:170 Page:90
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Murphy Sean M.¹,McCollister Kathryn E.²,Leff Jared A.¹,Yang Xuan²,Jeng Philip J.¹,Lee Joshua D.³,Nunes Edward V.⁴,Novo Patricia³,Rotrosen John³,Schackman Bruce R.¹

Affiliation:

1. Weill Cornell Medical College, New York, New York (S.M.M., J.A.L., P.J.J., B.R.S.)

2. University of Miami Miller School of Medicine, Miami, Florida (K.E.M., X.Y.)

3. New York University School of Medicine, New York, New York (J.D.L., P.N., J.R.)

4. Columbia University Medical Center, New York, New York (E.V.N.)

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Yoga and Physical Therapy for Chronic Pain and Opioid Use Disorder Onsite in an Opioid Treatment Program: A Randomized Controlled Trial;SUBST USE ADDICT J;2024

2. Reducing overdose deaths among persons with opioid use disorder in connecticut;Harm Reduction Journal;2024-05-28

3. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-09

4. Out-of-pocket spending and health care utilization associated with initiation of different medications for opioid use disorder: Findings from a national commercially insured cohort;Journal of Substance Use and Addiction Treatment;2024-04

5. The Medications for Opioid Use Disorder Study: Methods and Initial Outcomes From an 18-Month Study of Patients in Treatment for Opioid Use Disorder;Public Health Reports®;2024-01-25